MannKind | Costo Del Venduto



Cost Of Sales Cambiamento Data
Adma Biologics USD 54.22M 5.96M 2024-12
Dynavax Technologies USD 13.41M 326K 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Halozyme Therapeutics USD 42.06M 7.37M 2024-12
Insmed USD 26.15M 4.98M 2024-12
MacroGenics USD 1.87M 953K 2024-09
MannKind USD 17.6M 119K 2024-12
Merck USD 3.71B 181M 2024-12
Novo Nordisk DKK 11.31B 1.03B 2024-09
Pfizer USD 5.65B 781M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Xencor 10.71M 4.56M 2024-09



MannKind Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.